Indogulf Cropsciences Ltd
Incorporated in 1993, Indogulf Cropsciences Limited is engaged in manufacturing crop protection products, plant nutrients, and biologicals in India.[1]
- Market Cap ₹ 721 Cr.
- Current Price ₹ 114
- High / Low ₹ 122 / 101
- Stock P/E 23.2
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 13.2 %
- ROE 12.2 %
- Face Value ₹ 10.0
Pros
Cons
- Promoter holding has decreased over last quarter: -27.8%
- The company has delivered a poor sales growth of 3.78% over past five years.
- Company has a low return on equity of 12.9% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE IPO
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 492 | 443 | 486 | 549 | 553 | 592 | |
| 457 | 404 | 442 | 501 | 493 | 528 | |
| Operating Profit | 35 | 39 | 45 | 48 | 60 | 64 |
| OPM % | 7% | 9% | 9% | 9% | 11% | 11% |
| 3 | 2 | 4 | 3 | -2 | 6 | |
| Interest | 5 | 5 | 6 | 11 | 12 | 14 |
| Depreciation | 5 | 6 | 8 | 8 | 9 | 10 |
| Profit before tax | 28 | 31 | 36 | 31 | 36 | 45 |
| Tax % | 28% | 26% | 26% | 26% | 21% | 29% |
| 20 | 23 | 26 | 23 | 29 | 32 | |
| EPS in Rs | 52.30 | 9.77 | 11.26 | 9.80 | 12.19 | 6.58 |
| Dividend Payout % | 10% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 4% |
| 3 Years: | 7% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 6% |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 13% |
| Last Year: | 12% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 4 | 24 | 24 | 24 | 24 | 49 |
| Reserves | 127 | 131 | 157 | 180 | 209 | 228 |
| 92 | 79 | 102 | 189 | 155 | 222 | |
| 150 | 178 | 139 | 121 | 154 | 183 | |
| Total Liabilities | 373 | 411 | 421 | 513 | 541 | 682 |
| 47 | 51 | 53 | 65 | 44 | 47 | |
| CWIP | 4 | 6 | 9 | 9 | 22 | 57 |
| Investments | 3 | 3 | 0 | 0 | 0 | 0 |
| 319 | 352 | 359 | 440 | 474 | 578 | |
| Total Assets | 373 | 411 | 421 | 513 | 541 | 682 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| -17 | 20 | -9 | -59 | 36 | -12 | |
| -35 | -10 | -10 | -19 | -37 | -40 | |
| 52 | -9 | 20 | 77 | 0 | 58 | |
| Net Cash Flow | 0 | 1 | 0 | -1 | -1 | 6 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 88 | 97 | 115 | 117 | 146 | 140 |
| Inventory Days | 154 | 205 | 167 | 201 | 195 | 229 |
| Days Payable | 96 | 138 | 111 | 79 | 109 | 116 |
| Cash Conversion Cycle | 147 | 164 | 171 | 240 | 231 | 253 |
| Working Capital Days | 95 | 106 | 152 | 205 | 204 | 227 |
| ROCE % | 16% | 16% | 12% | 13% | 13% |
Documents
Announcements
-
Revised Outcome Of Board Meeting Held On July 24 2025
2h - Audited FY25 standalone and consolidated financial results approved; shares listed on BSE and NSE post public issue.
-
Results - Financial Year Ended March 31 2025
2h - Audited FY25 standalone and consolidated financial results approved; shares listed post public issue in July 2025.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On July 24, 2025, As per Regulation 30 And 33 Of The SEBI (LODR) Regulations, 2015
7h - Audited standalone and consolidated financial results for FY ended March 31, 2025 approved with unmodified audit opinion.
-
Board Meeting Intimation for Disclosure Of Audited Financial Results For The Quarter And Financial Year Ended On 31St March 2025
21 Jul - Board meeting on July 24 to approve FY 2024-25 audited results; trading window closed since July 3.
-
Intimation For Receipt Of Industry Leadership
Award 2025
12 Jul - Indogulf Cropsciences receives Industry Leadership Award 2025 for agricultural technology excellence.
Annual reports
No data available.
Business Profile[1]
Indogulf Cropsciences Limited is an agrochemical company engaged in the manufacturing and marketing of crop protection products, plant nutrients, and biologicals. It operates across India and exports to over 34 countries. It serves both retail (B2C) and institutional (B2B) customers and also offers contract manufacturing services.